Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.
オープンアクセス
-
- 石上 友章
- 横浜市立大学
書誌事項
- タイトル
- Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.
- 著者
- Kentaro Arakawa, Tomoaki Ishigami, et al.
収録刊行物
-
- PLoS One
-
PLoS One 14 2019
